Related references
Note: Only part of the references are listed.CPG 7909 adjuvant improves hepatitis B virus vaccine seroprotection in anti retroviral-treated HIV-infected adults
CL Cooper et al.
AIDS (2005)
Long-term efficacy of hepatitis B vaccine, booster policy, and impact of hepatitis B virus mutants
D FitzSimons et al.
VACCINE (2005)
Safety and immunogenicity of CPG 7909 injection as an adjuvant to Fluarix influenza vaccine
CL Cooper et al.
VACCINE (2004)
Immunogenicity and efficacy of childhood vaccines in HIV-1-infected children
SK Obaro et al.
LANCET INFECTIOUS DISEASES (2004)
CPG 7909, an immunostimulatory TLR9 agonist oligodeoxynucleotide, as adjuvant to Engerix-B® HBV vaccine in healthy adults:: A double-blind phase I/II study
CL Cooper et al.
JOURNAL OF CLINICAL IMMUNOLOGY (2004)
Delineation of a CpG phosphorothioate oligodeoxynucleotide for activating primate immune responses in vitro and in vivo
G Hartmann et al.
JOURNAL OF IMMUNOLOGY (2000)
Share Paper
